North Crest Asset Manangement, LLC Biomarin Pharmaceutical Inc Transaction History
North Crest Asset Manangement, LLC
- $4.13 Billion
- Q4 2025
A detailed history of North Crest Asset Manangement, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 12,483 shares of BMRN stock, worth $683,194. This represents 0.02% of its overall portfolio holdings.
Number of Shares
12,483
Previous 11,919
4.73%
Holding current value
$683,194
Previous $645,000
5.89%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding BMRN
# of Institutions
657Shares Held
182MCall Options Held
1.64MPut Options Held
984K-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$992 Million0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$833 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$804 Million0.46% of portfolio
-
State Street Corp Boston, MA8.76MShares$480 Million0.02% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...